| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.576 | 9.551 | 20.331 | 29.451 | 39.532 | 41.488 |
| Total Income - EUR | - | - | - | - | 4.576 | 9.551 | 20.331 | 29.451 | 39.532 | 41.488 |
| Total Expenses - EUR | - | - | - | - | 170 | 606 | 6.129 | 14.543 | 10.993 | 24.332 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.406 | 8.945 | 14.202 | 14.908 | 28.539 | 17.156 |
| Net Profit/Loss - EUR | - | - | - | - | 4.269 | 8.659 | 13.592 | 14.025 | 23.973 | 15.911 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sara Ginmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 376 | 606 | 865 | 1.416 | 4.659 | 29.743 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 804 |
| Receivables | - | - | - | - | 0 | 0 | 751 | 1.321 | 1.427 | 27.985 |
| Cash | - | - | - | - | 376 | 606 | 114 | 95 | 3.232 | 954 |
| Shareholders Funds | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 334 | 564 | 825 | 1.375 | 4.619 | 29.703 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sara Ginmed S.r.l.